最新消息

News & Message

:::
首頁/
最新消息/
期刊論文/
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

最新消息

2/3/2026

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

回上頁

相關文章

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
側邊開關圖示開關
首頁 Facebook Instagram 體系醫院 中國醫點通
▲至頂